MRPS35
gene geneOn this page
Also known as MRPS28MDS023mS35
Summary
MRPS35 (mitochondrial ribosomal protein S35, HGNC:16635) is a protein-coding gene on chromosome 12p11.22, encoding Small ribosomal subunit protein mS35 (P82673).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 28S subunit protein that has had confusing nomenclature in the literature. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Pseudogenes corresponding to this gene are found on chromosomes 3p, 5q, and 10q.
Source: NCBI Gene 60488 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 57 total
- Druggable target: yes
- MANE Select transcript:
NM_021821
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16635 |
| Approved symbol | MRPS35 |
| Name | mitochondrial ribosomal protein S35 |
| Location | 12p11.22 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MRPS28, MDS023, mS35 |
| Ensembl gene | ENSG00000061794 |
| Ensembl biotype | protein_coding |
| OMIM | 611995 |
| Entrez | 60488 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 11 protein_coding, 2 nonsense_mediated_decay
ENST00000081029, ENST00000536569, ENST00000538315, ENST00000542199, ENST00000542791, ENST00000898975, ENST00000898976, ENST00000898977, ENST00000898978, ENST00000939666, ENST00000939667, ENST00000939668, ENST00000942831
RefSeq mRNA: 2 — MANE Select: NM_021821
NM_001190864, NM_021821
CCDS: CCDS53769, CCDS8714
Canonical transcript exons
ENST00000081029 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001008073 | 27714780 | 27714820 |
| ENSE00001008074 | 27710832 | 27710955 |
| ENSE00002273609 | 27755181 | 27756295 |
| ENSE00003469386 | 27719808 | 27719868 |
| ENSE00003591582 | 27724047 | 27724186 |
| ENSE00003641578 | 27737539 | 27737608 |
| ENSE00003653513 | 27735447 | 27735556 |
| ENSE00003664214 | 27716291 | 27716458 |
Expression profiles
Bgee: expression breadth ubiquitous, 287 present calls, max score 96.49.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 56.9035 / max 717.7711, expressed in 1820 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 124844 | 56.9035 | 1820 |
Top tissues by expression
291 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| rectum | UBERON:0001052 | 96.49 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 95.81 | gold quality |
| calcaneal tendon | UBERON:0003701 | 95.72 | gold quality |
| adrenal tissue | UBERON:0018303 | 95.61 | gold quality |
| tibialis anterior | UBERON:0001385 | 95.39 | gold quality |
| muscle of leg | UBERON:0001383 | 95.34 | gold quality |
| gastrocnemius | UBERON:0001388 | 95.27 | gold quality |
| ileal mucosa | UBERON:0000331 | 95.16 | gold quality |
| deltoid | UBERON:0001476 | 95.07 | gold quality |
| muscle organ | UBERON:0001630 | 94.91 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 94.91 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 94.84 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.56 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 94.41 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 94.40 | gold quality |
| islet of Langerhans | UBERON:0000006 | 94.36 | gold quality |
| left adrenal gland | UBERON:0001234 | 94.20 | gold quality |
| ventricular zone | UBERON:0003053 | 94.04 | gold quality |
| quadriceps femoris | UBERON:0001377 | 93.95 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 93.95 | gold quality |
| vastus lateralis | UBERON:0001379 | 93.92 | gold quality |
| colonic mucosa | UBERON:0000317 | 93.77 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 93.71 | gold quality |
| adrenal gland | UBERON:0002369 | 93.70 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 93.68 | gold quality |
| cortical plate | UBERON:0005343 | 93.67 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 93.65 | gold quality |
| triceps brachii | UBERON:0001509 | 93.65 | gold quality |
| ganglionic eminence | UBERON:0004023 | 93.58 | gold quality |
| transverse colon | UBERON:0001157 | 93.47 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
49 targeting MRPS35, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-12119 | 99.87 | 68.35 | 1653 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-3151-5P | 99.86 | 63.83 | 1069 |
| HSA-MIR-4503 | 99.85 | 71.45 | 1869 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-3934-5P | 99.67 | 64.04 | 846 |
| HSA-MIR-4666B | 99.64 | 68.69 | 1282 |
| HSA-MIR-1915-3P | 99.58 | 66.79 | 1988 |
| HSA-MIR-3153 | 99.55 | 67.59 | 2337 |
| HSA-MIR-6083 | 99.47 | 68.73 | 2393 |
| HSA-MIR-5690 | 99.25 | 67.58 | 1012 |
| HSA-MIR-5584-3P | 99.23 | 68.79 | 1351 |
| HSA-MIR-544B | 99.18 | 67.41 | 1632 |
| HSA-MIR-491-5P | 99.13 | 65.98 | 1468 |
| HSA-MIR-4758-3P | 99.12 | 63.96 | 869 |
| HSA-MIR-10524-5P | 99.05 | 66.08 | 963 |
Literature-anchored findings (GeneRIF, showing 1)
- Circular RNA circMRPS35 represses malignant progression in osteosarcoma cells via targeting miR-105-5p/FOXO1. (PMID:39103205)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mrps35 | ENSDARG00000038456 |
| mus_musculus | Mrps35 | ENSMUSG00000040112 |
| rattus_norvegicus | Mrps35 | ENSRNOG00000001842 |
| drosophila_melanogaster | mRpS35 | FBGN0035374 |
| caenorhabditis_elegans | WBGENE00012697 |
Protein
Protein identifiers
Small ribosomal subunit protein mS35 — P82673 (reviewed: P82673)
Alternative names: 28S ribosomal protein S28, mitochondrial, 28S ribosomal protein S35, mitochondrial
All UniProt accessions (4): P82673, F5H612, H0YFD1, H0YG82
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial small ribosomal subunit (mt-SSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins.
Subcellular location. Mitochondrion.
Similarity. Belongs to the mitochondrion-specific ribosomal protein mS35 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P82673-1 | 1 | yes |
| P82673-2 | 2 |
RefSeq proteins (2): NP_001177793, NP_068593* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019349 | Ribosomal_mS35_mit | Domain |
| IPR039848 | Ribosomal_mS35_mt | Family |
Pfam: PF10213
UniProt features (35 total): helix 16, strand 8, turn 4, splice variant 2, transit peptide 1, chain 1, region of interest 1, coiled-coil region 1, sequence variant 1
Structure
Experimental structures (PDB)
77 structures, top 30 by resolution.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7QI4 | ELECTRON MICROSCOPY | 2.21 |
| 8CSS | ELECTRON MICROSCOPY | 2.36 |
| 7P2E | ELECTRON MICROSCOPY | 2.4 |
| 8RRI | ELECTRON MICROSCOPY | 2.4 |
| 9OLF | ELECTRON MICROSCOPY | 2.46 |
| 9OJM | ELECTRON MICROSCOPY | 2.5 |
| 8CSQ | ELECTRON MICROSCOPY | 2.54 |
| 8CSR | ELECTRON MICROSCOPY | 2.54 |
| 6ZM6 | ELECTRON MICROSCOPY | 2.59 |
| 7QI5 | ELECTRON MICROSCOPY | 2.63 |
| 8CSP | ELECTRON MICROSCOPY | 2.66 |
| 7PNX | ELECTRON MICROSCOPY | 2.76 |
| 8ANY | ELECTRON MICROSCOPY | 2.85 |
| 8CST | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | ELECTRON MICROSCOPY | 2.89 |
| 7PO0 | ELECTRON MICROSCOPY | 2.9 |
| 8K2A | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | ELECTRON MICROSCOPY | 2.9 |
| 7PO1 | ELECTRON MICROSCOPY | 2.92 |
| 7PO3 | ELECTRON MICROSCOPY | 2.92 |
| 9PGF | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | ELECTRON MICROSCOPY | 2.96 |
| 6RW4 | ELECTRON MICROSCOPY | 2.97 |
| 6VLZ | ELECTRON MICROSCOPY | 2.97 |
| 7QI6 | ELECTRON MICROSCOPY | 2.98 |
| 8QRN | ELECTRON MICROSCOPY | 2.98 |
| 9PSM | ELECTRON MICROSCOPY | 2.98 |
| 8OIS | ELECTRON MICROSCOPY | 3 |
| 9G5C | ELECTRON MICROSCOPY | 3 |
| 9G5D | ELECTRON MICROSCOPY | 3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P82673-F1 | 85.25 | 0.68 |
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
| R-HSA-5389840 | Mitochondrial translation elongation |
| R-HSA-5419276 | Mitochondrial translation termination |
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-5368287 | Mitochondrial translation |
| R-HSA-72766 | Translation |
MSigDB gene sets: 304 (showing top):
GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN, TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GOBP_MITOCHONDRIAL_TRANSLATION, TGACCTY_ERR1_Q2, GOBP_TRANSLATION, chr12p11, WEI_MYCN_TARGETS_WITH_E_BOX, ONKEN_UVEAL_MELANOMA_UP, WANG_LMO4_TARGETS_DN, GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME, GOCC_MITOCHONDRIAL_ENVELOPE, HNF4_01, NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
GO Biological Process (1): mitochondrial translation (GO:0032543)
GO Molecular Function (3): RNA binding (GO:0003723), structural constituent of ribosome (GO:0003735), protein binding (GO:0005515)
GO Cellular Component (7): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial small ribosomal subunit (GO:0005763), cytosol (GO:0005829), sperm head-tail coupling apparatus (GO:0120212), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 2 |
| cellular anatomical structure | 2 |
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| ribosome | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar small ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| intracellular membraneless organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
1940 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPS35 | MIX23 | Q4VC31 | 601 |
| MRPS35 | MRPS11 | P82912 | 572 |
| MRPS35 | SNX30 | Q5VWJ9 | 541 |
| MRPS35 | KAT7 | O95251 | 462 |
| MRPS35 | KGD4 | P82909 | 417 |
| MRPS35 | MRPS22 | P82650 | 409 |
| MRPS35 | H3BQ15 | H3BQ15 | 403 |
| MRPS35 | AMDHD2 | Q9Y303 | 396 |
| MRPS35 | SCCPDH | Q8NBX0 | 389 |
| MRPS35 | TMEM63A | O94886 | 382 |
| MRPS35 | VDAC1 | P21796 | 382 |
| MRPS35 | MRPL21 | Q7Z2W9 | 374 |
| MRPS35 | MRPS5 | P82675 | 350 |
| MRPS35 | BUD31 | P41223 | 349 |
| MRPS35 | TM7SF3 | Q9NS93 | 349 |
| MRPS35 | INTS13 | Q9NVM9 | 349 |
IntAct
209 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| ESR1 | TRIM24 | psi-mi:“MI:0914”(association) | 0.640 |
| LIN28A | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.640 |
| DAP3 | MRPS35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NP | KPNA6 | psi-mi:“MI:0914”(association) | 0.550 |
| MRPS18B | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF169 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| SNRNP70 | GTPBP1 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF331 | USP9Y | psi-mi:“MI:0914”(association) | 0.530 |
| PPAN | PPM1G | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS34 | ZZEF1 | psi-mi:“MI:0914”(association) | 0.530 |
| ZBTB48 | ZBTB24 | psi-mi:“MI:0914”(association) | 0.530 |
| E4F1 | ZBTB24 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS18C | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| TRMT10B | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| PDGFB | DKC1 | psi-mi:“MI:0914”(association) | 0.530 |
| IGF2BP3 | PTCD1 | psi-mi:“MI:0914”(association) | 0.530 |
| DAP3 | PNMA6A | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS15 | PRKACG | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS27 | YBX1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS26 | MRPS10 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF764 | SH3PXD2B | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL18 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS34 | MRPS12 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS11 | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| ABT1 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (404): MRPS35 (Affinity Capture-MS), MRPS35 (Affinity Capture-MS), MRPS35 (Affinity Capture-MS), MRPS35 (Affinity Capture-MS), MRPS35 (Affinity Capture-MS), MRPS35 (Affinity Capture-MS), MRPS35 (Affinity Capture-MS), MRPS35 (Affinity Capture-MS), MRPS35 (Affinity Capture-MS), MRPS35 (Affinity Capture-MS), ATP1B1 (Co-fractionation), DAP3 (Co-fractionation), MRPS18B (Co-fractionation), MRPS23 (Co-fractionation), MRPS31 (Co-fractionation)
ESM2 similar proteins: A4IHS0, A5WUX7, A6ZND9, B1P1W2, B3LIY9, B4KPG8, B5XAM2, D2HD32, E7EXT2, O44568, O94443, P25642, P34511, P82673, Q05863, Q08230, Q08DT6, Q08DU1, Q09691, Q12322, Q14197, Q2KI45, Q3T116, Q3UFY8, Q497V5, Q498P2, Q5RDI0, Q5U2R4, Q60R52, Q7JUX9, Q80VP5, Q8C1Z8, Q8K2Y7, Q8MT06, Q8N5C6, Q8R035, Q8VCE1, Q95Q11, Q9BRU9, Q9BVP2
Diamond homologs: P82673, Q2YDF6, Q498P2, Q8BJZ4
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPS35 | “form complex” | “28S mitochondrial small ribosomal subunit” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 234 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial translation | 27 | 24.8× | 6e-29 |
| Mitochondrial ribosome-associated quality control | 29 | 23.7× | 5e-30 |
| Mitochondrial translation initiation | 28 | 23.7× | 3e-29 |
| Mitochondrial translation elongation | 28 | 23.7× | 3e-29 |
| Mitochondrial translation termination | 28 | 20.5× | 2e-27 |
| Translation | 33 | 13.7× | 1e-26 |
| Peptide chain elongation | 11 | 9.3× | 1e-06 |
| Viral mRNA Translation | 11 | 9.3× | 1e-06 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial translation | 29 | 24.5× | 1e-29 |
| cytoplasmic translation | 13 | 11.7× | 3e-08 |
| translation | 22 | 11.0× | 4e-14 |
| regulation of alternative mRNA splicing, via spliceosome | 7 | 8.3× | 6e-03 |
| ribosomal small subunit biogenesis | 7 | 7.7× | 8e-03 |
| RNA processing | 7 | 7.4× | 8e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
57 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 34 |
| Likely benign | 8 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
2099 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:27716333:T:A | W66R | 0.992 |
| 12:27716333:T:C | W66R | 0.992 |
| 12:27724061:T:A | W133R | 0.992 |
| 12:27724061:T:C | W133R | 0.992 |
| 12:27737560:T:A | N218K | 0.992 |
| 12:27737560:T:G | N218K | 0.992 |
| 12:27716335:G:C | W66C | 0.990 |
| 12:27716335:G:T | W66C | 0.990 |
| 12:27716443:T:A | N102K | 0.989 |
| 12:27716443:T:G | N102K | 0.989 |
| 12:27719816:T:A | N110K | 0.989 |
| 12:27719816:T:G | N110K | 0.989 |
| 12:27719817:T:C | F111L | 0.988 |
| 12:27719819:T:A | F111L | 0.988 |
| 12:27719819:T:G | F111L | 0.988 |
| 12:27716391:T:A | V85D | 0.987 |
| 12:27724063:G:C | W133C | 0.986 |
| 12:27724063:G:T | W133C | 0.986 |
| 12:27737603:T:C | S233P | 0.986 |
| 12:27716363:T:C | F76L | 0.985 |
| 12:27716365:T:A | F76L | 0.985 |
| 12:27716365:T:G | F76L | 0.985 |
| 12:27755193:T:A | W239R | 0.985 |
| 12:27755193:T:C | W239R | 0.985 |
| 12:27737580:T:C | L225P | 0.983 |
| 12:27755195:G:C | W239C | 0.983 |
| 12:27755195:G:T | W239C | 0.983 |
| 12:27716458:G:C | K107N | 0.982 |
| 12:27716458:G:T | K107N | 0.982 |
| 12:27719818:T:C | F111S | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1000010454 (12:27741512 G>A), RS1000022731 (12:27750347 A>G), RS1000210355 (12:27746380 C>T), RS1000218549 (12:27722725 A>G,T), RS1000233666 (12:27710227 C>T), RS1000236280 (12:27739072 A>G), RS1000265670 (12:27739473 GAA>G,GA,GAAA), RS1000273961 (12:27715883 T>G), RS1000338833 (12:27739795 A>C), RS1000483230 (12:27754977 G>A), RS1000488575 (12:27709787 A>C), RS1000491672 (12:27731749 A>G), RS1000622126 (12:27725075 C>T), RS1000821268 (12:27731501 T>A), RS1000912601 (12:27734306 G>A)
Disease associations
OMIM: gene MIM:611995 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6066392 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 8.14 | Kd | 7.233 | nM | CHEMBL5653589 |
| 8.14 | ED50 | 7.233 | nM | CHEMBL5653589 |
PubChem BioAssay actives
1 with measured affinity, of 2 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2148780: Binding affinity to human MRPS35 incubated for 45 mins by Kinobead based pull down assay | kd | 0.0072 | uM |
CTD chemical–gene interactions
34 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | affects cotreatment, decreases expression | 3 |
| aristolochic acid I | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 1 |
| manganese chloride | increases abundance, increases expression, affects cotreatment | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2,3,5-(triglutathion-S-yl)hydroquinone | increases ADP-ribosylation | 1 |
| K 7174 | increases expression | 1 |
| ICG 001 | increases expression | 1 |
| bisphenol B | increases expression | 1 |
| bisphenol S | increases methylation | 1 |
| bisphenol AF | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Doxorubicin | increases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Ivermectin | decreases expression | 1 |
| Lipopolysaccharides | decreases expression, affects cotreatment | 1 |
| Manganese | increases expression, affects cotreatment, increases abundance | 1 |
| Ribonucleotides | affects binding | 1 |
| Rotenone | decreases expression | 1 |
| Testosterone | decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5651822 | Binding | Binding affinity to human MRPS35 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.